Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05697068 · ClinicalTrials.gov registry record · NA
Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos
A NA study of SARS CoV 2 Infection, sponsored by San Diego State University.
- Active
- Registry status
- NA
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT05697068: Active NA study of SARS CoV 2 Infection, sponsored by San Diego State University.
NCT05697068 is a NA study of SARS CoV 2 Infection that is active but no longer recruiting, run by San Diego State University. The registered enrollment target is 256 participants, below the 4,180-participant average among 35 other SARS CoV 2 Infection trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05697068, a NA study of SARS CoV 2 Infection, is active but no longer recruiting, sponsored by San Diego State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will examine the effectiveness of a 6-week behavioral intervention for patients who are recently diagnosed with COVID-19. Patients and their households will be randomized to one of two groups (Standard of Care vs. Enhanced Standard of Care). Patients in the Standard-of-Care group will receive established clinical care and follow-up. Patients in the Enhanced Standard-of-Care group will receive standard-of-care plus tailored, real-time text messaging and virtual counseling delivered by promotores/as. The investigators hypothesize that households in the Enhanced Standard-of-Care group will have fewer (any new) household COVID-19 infectivity rates compared to households in the standard-of-care group post-intervention.
Primary Outcome
Antibodies assessed by a blood draw collected by a certified phlebotomist. SARS-CoV-2 Nucleocapsid and Spike Protein IgG, used to accurately determine prior infection and/or vaccination.
Conditions Studied
Interventions
- BEHAVIORAL COVID Prevention Program (CPP)
Study Locations (1)
California
- San Diego State University Research Foundation - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2022-04-11 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
What the registry record for NCT05697068 still lists
NCT05697068 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 4,180-participant average among 35 other SARS CoV 2 Infection trials with a reported enrollment target (94% lower).
The record links to 1 condition, with SARS CoV 2 Infection appearing as the primary indexed condition, and to 1 intervention - of which COVID Prevention Program (CPP) is the first listed.
NCT05697068 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05697068 about?
NCT05697068 is a clinical study titled "Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos". This study will examine the effectiveness of a 6-week behavioral intervention for patients who are recently diagnosed with COVID-19. Patients and their households will be randomized to one of two groups (Standard of Care vs. Enhanced Standard of Care). Patients in the Standard-of-Care group will rec...
What is the current status of trial NCT05697068?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 256 participants. The study started on 2022-04-11. Estimated completion is 2025-10-31.
What conditions does trial NCT05697068 study?
This clinical trial studies the following conditions: SARS CoV 2 Infection.
What interventions are being tested in trial NCT05697068?
The interventions under investigation include: COVID Prevention Program (CPP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05697068?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05697068 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for SARS CoV 2 Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05697068's enrollment target sits among peer trials
256 24th of 35 higher than 12 of 35 other SARS CoV 2 Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other SARS CoV 2 Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise in Child Health
RECRUITING · NA
-
Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome
RECRUITING · NA
-
Safe and Healthy Schools
COMPLETED · NA
-
Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake
COMPLETED · NA
-
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
RECRUITING
-
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI